March 2026 in “Mendeley Data” Placebo treatments can improve hair growth and satisfaction in hair loss.
March 2026 in “Mendeley Data” Placebo treatments can improve hair growth and satisfaction in hair loss.
March 2026 in “Skin Appendage Disorders” Telogen effluvium is linked to low ferritin and vitamin D levels.
Low ferritin and vitamin D levels are linked to hair loss.
Low ferritin and vitamin D levels are linked to hair loss, suggesting the need for personalized nutrition and diagnostics.
March 2026 in “Dermatology and Therapy” This systematic review and meta-analysis evaluated the prevalence and risk of comorbidities in patients with discoid lupus erythematosus (DLE), including 25 studies. It found high prevalence rates of systemic lupus erythematosus (22.0%), hypertension (24.3%), depression (38.8%), and hypothyroidism (12.4%) among DLE patients. Significant associations were identified between DLE and cardiovascular disease, hypothyroidism, hypertension, depression, and anxiety, though associations with type 2 diabetes were modest and smoking was not significant. The study emphasizes the need for comprehensive clinical assessment and multidisciplinary management of DLE patients, while noting that the associations should be interpreted cautiously due to limited evidence.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Herbal hair oils effectively address common hair issues with minimal side effects.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Herbal hair oils effectively address common hair issues with minimal side effects.
March 2026 in “Mendeley Data” Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.
March 2026 in “Mendeley Data” Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.
January 2026 in “BMC Public Health” Family history, smoking, alcohol, poor sleep, obesity, and insulin issues increase the risk of hair loss.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Exosomes and stem-cell therapies slightly outperform PRP in improving hair and skin, but more research is needed.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Exosomes and stem-cell therapies slightly outperform PRP in improving hair and skin, but more research is needed.
January 2026 in “Nutrients” This systematic review evaluated the effects of probiotic supplementation on mental health and sleep quality in women with polycystic ovary syndrome (PCOS). Analyzing five randomized controlled trials, the review found that probiotics were associated with significant improvements in sleep quality, depressive symptoms, and some aspects of quality of life. However, the evidence is limited due to the small number of studies, modest sample sizes, and methodological variability. Further research with larger and more rigorous studies is necessary to confirm these findings.
January 2026 in “International Journal of Medicine in Developing Countries” Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.
January 2026 in “British Journal of Dermatology” Combined microneedling with minoxidil improves hair growth more than minoxidil alone for hair loss.
January 2026 in “Dermatologic Therapy” Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.
January 2026 in “Spectrum Research Repository (Concordia University)” Alopecia affects identity and social interactions, requiring personalized support and better healthcare collaboration.
December 2025 in “Pakistan Journal of Health Sciences” Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.
December 2025 in “International Journal of Innovative Technologies in Social Science” Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.
December 2025 in “Journal of Surgery” This technique improves delivery and effectiveness of exosomes for tissue regeneration.
December 2025 in “International Journal of Dermatology” Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.
December 2025 in “Journal of Cosmetic Dermatology” Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.
December 2025 in “Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)” Botulinum toxin may reduce inflammation markers in head and neck conditions, but evidence is uncertain.
November 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” Androgenetic alopecia negatively impacts mental health, suggesting a need for psychological support in treatment.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” PRP may be more effective and satisfying for hair regrowth than minoxidil, with similar safety.
October 2025 in “International Journal of Dermatology” GLP-1 receptor agonists may cause hair loss, but regrowth is rare.
October 2025 in “Acta Dermato Venereologica” Spontaneous hair regrowth in alopecia areata is possible but varies greatly among individuals.
October 2025 in “JEADV Clinical Practice” Minoxidil may help hair regrowth in traction alopecia, but changing hair habits is the main treatment.
October 2025 in “International Journal of Nutrology” Improving gut health can enhance skin health and aid in treating skin diseases.